Eli Lilly executives say the company currently accounts for more than 30% of the new prescriptions in the oral obesity treatment market.

Zhitongcaijing · 4d ago
Eli Lilly executives say the company currently accounts for more than 30% of the new prescriptions in the oral obesity treatment market.